What is Ebglyss?
Ebglyss (lebrikizumab-lbkz) is a biologic drug, specifically a humanized monoclonal antibody targeting interleukin-13 (IL-13) for moderate-to-severe atopic dermatitis.[1]
How Does Ebglyss Work?
It binds to IL-13, blocking its signaling pathway that drives skin inflammation. As a monoclonal antibody, it's produced in living cells, distinguishing it from small molecules synthesized chemically.[1][2]
Biologic vs. Small Molecule: Key Differences
Biologics like Ebglyss are large proteins (around 150 kDa) derived from biotech processes, requiring refrigeration and injection. Small molecules are under 1 kDa, chemically made, often oral, and easier to manufacture.[2]
| Feature | Ebglyss (Biologic) | Small Molecules |
|------------------|--------------------|-------------------|
| Size | ~150 kDa | <1 kDa |
| Production | Cell-based | Chemical synthesis |
| Administration | Subcutaneous injection | Often oral |
| Stability | Refrigerated | Room temperature |
| Examples | Ebglyss, Dupixent | JAK inhibitors |
Approval and Development
FDA approved Ebglyss in September 2024 for adults with atopic dermatitis not controlled by other systemic therapies. Developed by Eli Lilly (acquired from Almirall), it's the first IL-13-targeting biologic.[1]
Patent Status on DrugPatentWatch
No active patents listed for Ebglyss on DrugPatentWatch.com as of latest data; check DrugPatentWatch.com for updates on formulations or methods.[3]
Compared to Other Atopic Dermatitis Treatments
| Drug | Type | Target |
|------------------|------------|-----------------|
| Ebglyss | Biologic | IL-13 |
| Dupixent | Biologic | IL-4/IL-13 |
| Cibinqo | Small Molecule | JAK1 |
| Rinvoq | Small Molecule | JAK |
Biologics like Ebglyss offer targeted efficacy but higher costs (~$40,000/year) vs. small molecules (~$5,000/year).[2]
Sources:
[1] FDA Label: https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761350s000lbl.pdf
[2] Eli Lilly Prescribing Info: https://pi.lilly.com/us/ebglyss-uspi.pdf
[3] DrugPatentWatch: https://www.drugpatentwatch.com/p/tradename/EBGLYSS